Streptococcal Infections
📧 Sign up to get email alerts when something new happens for Streptococcal Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Systematic Search for Primary Immunodeficiency in Adults With Infections [NA]
This is a completed clinical trial update for NCT02972281, describing a systematic search to identify primary immunodeficiency in adults wit…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks) [Phase 3]
This clinical trial update reports on a Phase 3 study to evaluate the immunogenicity and safety of a 13-valent pneumococcal conjugate vaccin…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Factors Associated With Mortality in Streptococcal Anginosus Bacteremia
This ClinicalTrials.gov entry describes a recruiting study at University Hospital Strasbourg investigating factors associated with mortality…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Aluminum Hydroxide (Alum) or AS37 in Healthy Young Adults [Phase 1]
Phase 1 study to evaluate safety, reactogenicity, and immunogenicity of GlaxoSmithKline's 4-component Strep A vaccine in healthy young adult…
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i) [Phase 3]
Phase III clinical trial of a candidate PCV13 vaccine in healthy individuals aged 6 weeks and above has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-12-10FDA Approved: BICILLIN C-R 900/300 — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Bicillin C-R 900/300 (penicillin G benzathine and penicillin G procaine) by Pfizer, updating…
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A [Phase 3]
Phase 3 trial update on a GlaxoSmithKline pneumococcal conjugate vaccine (1024850A) reporting its immunogenicity, safety, and impact on carr…
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese Children [Phase 3]
A Phase 3 study evaluating primary and booster vaccination with the pneumococcal vaccine GSK1024850A in healthy Japanese children has comple…
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A [Phase 3]
Phase 3 trial results for immunization of young children with GSK pneumococcal vaccine GSK1024850A have been completed with results posted.
-
CLINICAL_TRIALS research · 2019-02-04Clinical Trial Update: Rheumatic Heart Disease Prevalence in Leon, Nicaragua
This completed clinical trial study assesses the prevalence of rheumatic heart disease in Leon, Nicaragua, in relation to Streptococcus Grou…
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A [Phase 3]
Phase 3 study evaluating prophylactic antipyretic treatment in children receiving a booster dose of a pneumococcal conjugate vaccine has com…
-
CLINICAL_TRIALS trial_result · 2019-01-14Clinical Trial Update: Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines [Phase 3]
Phase 3 clinical trial update on a pneumococcal vaccine booster in healthy children aged 12-18 months previously primed with the same vaccin…
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants [Phase 3]
A Phase 3 trial evaluating safety and immunogenicity of a 10-valent pneumococcal conjugate vaccine in preterm infants has completed and resu…
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib [Phase 3]
Phase 3 trial comparing co-administration of pneumococcal vaccine with different combination vaccines; results completed and posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-26Clinical Trial Update: Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine. [Phase 3]
Phase 3 safety and immunogenicity results for a booster dose of GSK's 10-valent pneumococcal conjugate vaccine have been completed with resu…
-
FDA approval · 2018-02-21FDA Approved: VANCOMYCIN HYDROCHLORIDE — Supplemental Application (SAMSON MEDICAL TECHNOLOGIES LLC)
The FDA approved Samson Medical Technologies LLC's supplemental application for vancomycin hydrochloride, a generic antibiotic, under an app…
-
FDA approval · 2017-12-07FDA Approved: BICILLIN C-R 900/300 — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Bicillin C-R 900/300 (penicillin G benzathine and penicillin G procaine) from Pfizer. The action…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™ [Phase 3]
Phase 3 trial assessing primary vaccination course in children receiving pneumococcal vaccine GSK 1024850A, Zilbrix Hib, and Sabin polio; st…
-
CLINICAL_TRIALS trial_result · 2017-09-12Clinical Trial Update: Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children [Phase 2]
Phase 2 clinical trial update on a vaccine aimed at reducing ear and lung infections in children has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children [Phase 3]
Phase 3 long-term follow-up study of children previously primed or unprimed with GSK pneumococcal vaccine; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine [Phase 2]
Phase 2 trial assessing safety and immunogenicity of liquid and lyophilized formulations of a trivalent Group B Streptococcus vaccine; resul…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population [Phase 1]
This entry documents completion of a Phase 1 study assessing the safety and immunogenicity of an investigational pneumococcal vaccine in eld…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Booster and Catch-up Vaccination With Vaccine GSK1024850A [Phase 3]
Phase 3 trial update on booster and catch-up vaccination with GSK1024850A; completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam [Phase 3]
Phase 3 trial update of GSK's pneumococcal vaccine in healthy infants in Vietnam has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™ [Phase 3]
Phase 3 trial updating primary vaccination with Synflorix or Prevnar 13 or both, and booster with Synflorix; study completed with results po…